ctrl K

Watchlist Price Alert

EyeGate Pharmaceuticals I... (EYEG)

NASDAQ: EYEG · Real-Time Price · USD

35.47

0.41 (1.17%)

At close: Jul 03, 2025, 1:04 PM

EyeGate Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	16.02M	12.06K	2.69M	1.65M	407.52K	669.26K
Cost of Revenue	n/a	12.05K	n/a	n/a	n/a	n/a
Gross Profit	16.02M	13.00	2.69M	1.65M	407.52K	669.26K
Operating Income	2.64M	-8.21M	-7.11M	-10.84M	-14.56M	-13.35M
Interest Income	1.25M	23.34K	108.07K	120.36K	564.00	3.68K
Pretax Income	5.66M	-8.08M	-7M	-10.73M	-14.56M	-13.34M
Net Income	7.72M	-8.09M	-7.1M	-10.81M	-13.22M	-13.34M
Selling & General & Admin	5.54M	4.66M	4.41M	4.44M	4.64M	5.59M
Research & Development	7.84M	3.57M	5.39M	8.06M	10.33M	8.42M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	13.38M	8.22M	9.8M	12.5M	14.97M	14.02M
Interest Expense	-21.45K	4.19K	325.00	1.04K	1.22K	275.00
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	13.38M	8.22M	9.8M	12.5M	14.97M	14.02M
Income Tax Expense	-2.07M	12.05K	95.4K	86.05K	-1.34M	3.68K
Shares Outstanding (Basic)	3.87M	3.18M	3.18M	2.37M	950.68K	588.93K
Shares Outstanding (Diluted)	4.13M	3.18M	3.18M	2.37M	950.68K	588.93K
EPS (Basic)	1.99	-2.54	-2.23	-4.57	-13.9	-22.66
EPS (Diluted)	1.87	-2.54	-2.23	-4.57	-13.9	-22.66
EBITDA	n/a	-8.04M	-6.79M	-10.69M	-14.54M	-13.34M
EBIT	5.64M	-8.08M	-7M	-10.72M	-14.56M	-13.34M
Depreciation & Amortization	n/a	33.4K	213.93K	38.48K	19.29K	5.18K